- Home
- Test Catalog Search
- 9562U
4-carboxy-AMB-PINACA [LC-MS/MS]:
5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole)
5-fluoro-PIC-ACID [LC-MS/MS]:
5-fluoro-PICA 3,3-dimethylbutanoic acid
FUBINACA 3,3-dimethylbutanoic acid [LC-MS/MS]:
Quetiapine
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
Additional Collection Instructions
Rejection criteria pertain to clinical specimen submissions only.
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
1 | 4-carboxy-AMB-PINACA | AB-PINACA N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PIC-ACID (5-Fluoro-PB-22 3-Carboxyindole) |
2 | FUBICA 3,3-dimethylbutanoic acid | MDMB-FUBICA Metabolite 3 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
3 | 5-fluoro-PINAC-ACID | 5F-NPB-22-Carboxyindazole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
4 | 4-carboxy-CUMYL-BINACA | CUMYL-BUTINACA N-Butanoic Acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
5 | 5-fluoro-PIC-ACID | 5-Fluoro-PB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | 5-fluoro-PICA 3,3-dimethylbutanoic acid |
6 | FUBIC-ACID | FUB-PB-22-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 40 | Synthetic Cannabinoid | |
7 | 5-fluoro-PINACA 3-methylbutanoic acid | 5F-AMB 3-methyl-butanoic acid; 5F-AMB M7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
8 | FUBINACA 3-methylbutanoic acid | FUB-AMB 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | |
9 | 5-fluoro-PINACA 3,3-dimethylbutanoic acid | 5F-ADB 3,3-dimethyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
10 | FUBINACA 3,3-dimethylbutanoic acid | MDMB-FUBINACA 3,3-dimethyl-butanoic acid; MDMB-FUBINACA M1 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.5 | Synthetic Cannabinoid | Quetiapine |
11 | CHMINACA-3-methylbutanoic acid | AB-CHMINACA 3-methyl-butanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 2.5 | Synthetic Cannabinoid | |
12 | 4-carboxy-NA-PIM | JWH-018 N-pentanoic acid | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
13 | CHMINACA 3,3-dimethylbutanoic acid | ADB-CHMINACA 3,3-dimethyl-butanoic acid; ADB-CHMINACA M2, MAB-CHMINACA M2 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid | |
14 | CHMIC-ACID | BB-22 3-Carboxyindole | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 5 | Synthetic Cannabinoid | |
15 | 5-fluoro-PICA 3,3-dimethylbutanoic acid | 5F-MDMB-PICA metabolite 7 | High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) | ng/mL | 0.2 | Synthetic Cannabinoid |
Interface Mapping
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
LOINC® Information
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.
*The information contained in this document represents database configurations, as they will appear on the effective date listed above.
Test Code 9562U
Test Name Synthetic Cannabinoid Metabolites Screen - Expanded (2019 Scope), Urine